KV Again Shakes Suit Over Metoprolol Recall

Law360, New York (December 16, 2011, 5:38 PM EST) -- A Missouri federal judge on Thursday again tossed a putative class action against KV Pharmaceutical Co. over its recall of hypertension drug metoprolol succinate ER, finding the plaintiff had failed to prove that the medication was defective.

U.S. District Judge Stephen N. Limbaugh Jr. ruled that plaintiff Johnny Polk could not maintain his Missouri Merchandising Practices Act and breach of implied warranty of merchantability claims based solely on the allegations contained in a previous consent decree that KV reached with the U.S. Food and Drug Administration,...
To view the full article, register now.




Case Information

Case Title

Lefaivre v. KV Pharmaceutical Company, et al.

Case Number



Missouri Eastern

Nature of Suit

Tort Product Liability


Stephen N. Limbaugh, Jr

Date Filed

April 15, 2009

Law Firms


Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.